newsfilter
← Latest News
GlobeNewswire·

Achilles Therapeutics Announces Voluntary Nasdaq Delisting and SEC Deregistration

LONDON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ:ACHL) (the Company) today announced that it has formally notified The Nasdaq Stock Market LLC (Nasdaq) of its intention to voluntarily delist